Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma 19Lymphoma, Large B-Cell, Diffuse 16Leukemia 11Lymphoma, Non-Hodgkin 10Burkitt Lymphoma 10Recurrence 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 6Neoplasms 5Lymphoma, B-Cell 5Leukemia, Myeloid, Acute 4Multiple Myeloma 3Medulloblastoma 3Lymphoma, T-Cell, Peripheral 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Sarcoma, Ewing 2Neuroblastoma 2Neoplasms by Histologic Type 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Lymphatic Diseases 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2

Interventions

ibrutinib 1deltacortene 1Vincristine 1Rituximab 1Prednisone 1Methotrexate 1Hyaluronoglucosaminidase 1Etoposide 1Doxorubicin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Multi-centric Castleman's Disease × Vincristine × Clear all
NCT03864419 2024-01-03

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Fred Hutchinson Cancer Center

Phase 1 Terminated
18 enrolled
Lymphoid

Multi-centric Castleman's Disease, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡